Using CRISPR as a research tool to develop cancer treatments
KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology.
KSQ Therapeutics uses technology created at MIT to study the role of every human gene in disease biology.
MIT researchers have developed a publicly available model based on physics and data from past spreading events.
MIT spinout OPT Industries uses novel additive manufacturing systems to create intricately-designed products.
MIT research combines machine learning with nanoparticle design for personalized drug delivery.
Regina Barzilay, Fotini Christia, and Collin Stultz describe how artificial intelligence and machine learning can support fairness, personalization, and inclusiveness in health care.
Research on how water behaves in a proton channel provides possible new avenues for flu treatment.
Saha Global, co-founded by two MIT alumnae, helps Ghanaian women start profitable water treatment businesses to serve their communities.
The gene variant disrupts lipid metabolism, but in cell experiments the effects were reversed by choline supplements.
A new computational approach for analyzing complex datasets shows that as disease progresses, neurons and astrocytes lose the ability to maintain homeostasis.
With deep roots at MIT, the startup change:WATER Labs has created a toilet that treats waste without water or power.
Trained dogs can detect cancer and other diseases by smell. A miniaturized detector can analyze trace molecules to mimic the process.
Researchers develop a system to identify drugs that might be repurposed to fight the coronavirus in elderly patients.
Pison, founded by Dexter Ang ’05, enables people to control digital interfaces, such as their phones, through brain signals.
Scalable CRISPRi system from SMART allows scientists to identify and tackle causes of E. faecalis-related diseases and drug resistance.
Case’s new lab investigates why cancer arises when disruptions in cellular organization change how cells sense mechanical forces.